Sofosbuvir/ velpatasvir


( Last Updated : March 23, 2016)
Generic Name:
Sofosbuvir/ velpatasvir
Project Status:
Complete
Therapeutic Area:
Hepatitis C, chronic
Manufacturer:
Gilead Sciences Canada, Inc.
Call for patient/clinician input open:
Brand Name:
Epclusa
Project Line:
Reimbursement Review
Project Number:
SR0486-000
Call for patient/clinician input closed:

Details


Submission Type:
Initial
Indications:
Hepatitis C, chronic
Recommendation Type:
Reimburse with clinical criteria and/or conditions
Final Recommendation: